lncRNA GHET1 has effects in development of pre-eclampsia

Area of Science:

• Reproductive Biology
• Molecular Genetics
• Cell Biology

Background:

• Pre-eclampsia is a pregnancy complication with significant maternal and fetal morbidity.
• The role of long noncoding RNAs (lncRNAs) in pre-eclampsia pathogenesis is increasingly recognized.
• Gastric carcinoma high expressed transcript 1 (GHET1) is a lncRNA implicated in various cellular processes.

Purpose of the Study:

• To investigate the role and mechanism of lncRNA GHET1 in the development of pre-eclampsia.
• To evaluate the impact of GHET1 expression on trophoblast cell function under hypoxic conditions.

Main Methods:

• Hematoxylin and eosin staining to assess pathological changes in pre-eclampsia tissues.
• Reverse-transcription polymerase chain reaction (RT-PCR) to quantify lncRNA GHET1 expression.
• In vitro cell assays (Transwell, wound-healing) to measure trophoblast cell invasion and migration.
• Western blot analysis to determine protein expression levels (E-cadherin, fibronectin, vimentin).

Main Results:

• lncRNA GHET1 expression was significantly downregulated in pre-eclampsia tissues compared to normal tissues.
• Hypoxia suppressed JEG3 cell invasion and migration, evidenced by reduced invasion cell numbers and wound-healing rates.
• Overexpression of lncRNA GHET1 in JEG3 cells under hypoxia restored cell invasion and migration abilities.
• Significant alterations in E-cadherin, fibronectin, and vimentin protein expression were observed between groups.

Conclusions:

• lncRNA GHET1 plays a crucial role in regulating trophoblast cell function during pre-eclampsia.
• GHET1 overexpression can counteract the negative effects of hypoxia on cell invasion and migration, suggesting a protective role.
• Targeting lncRNA GHET1 may offer a potential therapeutic strategy for pre-eclampsia.